Evidence map›Paper›PMID 28316259›Full record

ReviewTissue engineering. Part B, Reviews2018

The Adipose Stromal Vascular Fraction as a Complex Cellular Source for Tissue Engineering Applications.

Venkat M Ramakrishnan, Nolan L Boyd

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Tissue engineering. Part B, Reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04391621 phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

Efficacy of Autologous Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids

TypeinterventionalSponsorMakerere UniversityRan2021 to 2023Enrolled30ConditionsAdipose Derived Stem Cells, KeloidArmsAutologous Adipose Derived stem cell transplantation, Triamcinolone Acetonide 40Mg/Ml Inj,Susp_#1
NCT04553159 phase2completednot on this mapstarted 2021, after this paper: background citation

Autologous Adipose Derived Stem Cell Transplantation in the Treatment of Keloids. A Pilot Randomized Controlled Trial

TypeinterventionalSponsorMakerere UniversityRan2021 to 2021Enrolled8ConditionsKeloid, Autologus Adipose Derived Stem Cells, Feasibility, SafetyArmsAutologous adipose derived stem cells
3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Venkat M RamakrishnanCardiovascular Innovation Institute, Department of Physiology, University of Louisville School of Medicine , Louisville, Kentucky.
Nolan L BoydCardiovascular Innovation Institute, Department of Physiology, University of Louisville School of Medicine , Louisville, Kentucky.
University of Louisville · US

Funding

Vascularized cell-based device for restoring physiological homeostasisR21EB022185 · NIBIB · UNIVERSITY OF LOUISVILLE · PI BOYD, NOLAN LEE · 2016 to 2017
$419k
NIBIB NIH HHS R21 EB022185
6 · The paper itself

Abstract

A major challenge in tissue engineering is the generation of sufficient volumes of viable tissue for organ transplant. The development of a stable, mature vasculature is required to sustain the metabolic and functional activities of engineered tissues. Adipose stromal vascular fraction (SVF) cells are an easily accessible, heterogeneous cell system comprised of endothelial cells, macrophages, pericytes, and various stem cell populations. Collectively, SVF has been shown to spontaneously form vessel-like networks in vitro and robust, patent, and functional vasculatures in vivo. Capitalizing on this ability, we and others have demonstrated adipose SVF's utility in generating and augmenting engineered liver, cardiac, and vascular tissues, to name a few. This review highlights the scientific origins of SVF, the use of SVF as a clinically relevant vascular source, various SVF constituents and their roles, and practical considerations associated with isolating SVF for various tissue engineering applications.

Indexed as

Adipose TissueNeovascularization, PhysiologicStem CellsAnimalsCell SeparationHumansTissue Engineeringadipose tissuelipoaspiratestromal vascular fractionvasculature

Identifiers

PMID28316259
PMCPMC6080106
OpenAlexW2598337322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.